ANN ARBOR — The Michigan Health Information Network Shared Services has added Dr. Andrew Rosenberg, M.D. has been appointed to the company’s Board of Directors. His appointment is effective Oct. 20. Rosenberg, a tenured Associate Professor of Anesthesiology, Critical Care, & Internal Medicine at the University of Michigan, was appointed to a three-year term unanimously
ANN ARBOR - Michigan’s life sciences industry grew into a $28 billion sector over decades, but it took the pandemic for many in the state to recognize just how essential it is. “Obviously we’re the industry that’s in the bull’s-eye of it all, whether it’s trying to come up with a vaccine or manufacturing enough PPE (Personal Protective Equipment)
ANN ARBOR—Officials of Swift Biosciences, a developer of gene sequencing technology, and BillionToOne, a Menlo Park, Calif. diagnostics company, announced that Swift Bioscience will be the exclusive distributor of BillionToOne’s RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity testing of up to a million tests per day. The test is designed to detect
GRAND RAPIDS — Grand Valley State University's Kirkhof College of Nursing received a $500,000 grant from the Michigan Health Endowment Fund to offer a unique model of integrated behavioral health and primary care to a vulnerable population in Grand Rapids. The two-year grant establishes Project Thrive and offers fully integrated services at the GVSU Family
LANSING - Pharmaceutical companies would have to report to the state and the public annually how they set the prices of their prescription drugs under an eight-bill transparency package approved by the Michigan House Health Policy Committee. But the committee rejected, in party-line fashion, several attempts by Democrats to put more teeth into the bills,
LANSING—Connected Nation Michigan, the state’s unit of the broadband advocacy group Connected Nation, will host a webinar on telehealth usage and advances for patients and doctors on Tuesday, Sept. 22. The event, set to begin at 11 a.m. Eastern time, will feature a discussion with Ryan Palmer, chief of the Telecommunications Access Policy Division within
DALLAS—Four teams of scientific researchers have been named finalists in the first phase of the American Heart Association COVID-19 Data Challenge, which focuses on understanding the relationships between COVID-19 and other health conditions, health disparities, and social determinants of health that may bring a higher burden of illness or mortality. After peer review by a
ANN ARBOR—Terumo Cardiovascular, a cardiovascular surgery products provider, announced a collaboration with Monmouth Junction, N.J.-based CytoSorbents Corp., to sell the latter company’s product CytoSorb to hospitals in 10 COVID-19 hotspot states. The states are Alabama, Arizona, California, Georgia, Louisiana, Mississippi, New Mexico, Oregon, Texas, and Washington. The product is designed to treat cytokine storm, a
ANN ARBOR - Eran Bashan, CEO of Hygieia, explains how his d-Nav program takes the guesswork out of insulin dosing for people who inject daily. It automates insulin dose prescribing using AI and patented technology in an FDA-cleared mobile app. The program includes clinical care support either virtually, or in a Hygieia clinic. The app
LIVONIA - With coronavirus infection rates fluctuating throughout the United States, millions of people with Type 2 diabetes and uncontrolled blood sugar levels remain at elevated risk for serious complications from the disease. In response, physician specialists and scientists from Hygieia have introduced a fully virtual option for their d-Nav® Insulin Management Program. “Ninety percent
